These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10203053)

  • 61. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.
    Kent SJ; Hu SL; Corey L; Morton WR; Greenberg PD
    J Virol; 1996 Aug; 70(8):4941-7. PubMed ID: 8763998
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.
    Patterson LJ; Malkevitch N; Pinczewski J; Venzon D; Lou Y; Peng B; Munch C; Leonard M; Richardson E; Aldrich K; Kalyanaraman VS; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(16):8607-20. PubMed ID: 12885879
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
    McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
    J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
    Amara RR; Patel K; Niedziela G; Nigam P; Sharma S; Staprans SI; Montefiori DC; Chenareddi L; Herndon JG; Robinson HL; McClure HM; Novembre FJ
    J Virol; 2005 Dec; 79(24):15356-67. PubMed ID: 16306607
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.
    Wang C; Jiang C; Gao N; Zhang K; Liu D; Wang W; Cong Z; Qin C; Ganusov VV; Ferrari G; LaBranche C; Montefiori DC; Kong W; Yu X; Gao F
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28574482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
    Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
    J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
    Patterson LJ; Peng B; Abimiku AG; Aldrich K; Murty L; Markham PD; Kalyanaraman VS; Alvord WG; Tartaglia J; Franchini G; Robert-Guroff M
    AIDS; 2000 Nov; 14(16):2445-55. PubMed ID: 11101054
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge.
    Negri DRM; Baroncelli S; Catone S; Comini A; Michelini Z; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Boros S; Liljestrom P; Norley S; Heeney J; Titti F
    J Gen Virol; 2004 May; 85(Pt 5):1191-1201. PubMed ID: 15105535
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge.
    Vogel TU; Beer BE; Zur Megede J; Ihlenfeldt HG; Jung G; Holzammer S; Watkins DI; Altman JD; Kurth R; Norley S
    J Gen Virol; 2002 Jan; 83(Pt 1):81-91. PubMed ID: 11752704
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.
    Hu SL; Abrams K; Barber GN; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    Science; 1992 Jan; 255(5043):456-9. PubMed ID: 1531159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.
    Wang C; Gao N; Song Y; Duan S; Wang W; Cong Z; Qin C; Jiang C; Yu X; Gao F
    Microbiol Immunol; 2020 Jan; 64(1):52-62. PubMed ID: 31544982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.
    Berry N; Ham C; Mee ET; Rose NJ; Mattiuzzo G; Jenkins A; Page M; Elsley W; Robinson M; Smith D; Ferguson D; Towers G; Almond N; Stebbings R
    PLoS One; 2011; 6(8):e23092. PubMed ID: 21853072
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens.
    Toledo NPL; Li H; Omange RW; Dacoba TG; Crecente-Campo J; Schalk D; Kashem MA; Rakasz E; Schultz-Darken N; Li Q; Whitney JB; Alonso MJ; Plummer FA; Luo M
    Front Immunol; 2020; 11():1935. PubMed ID: 32983121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mucosal challenge of Macaca nemestrina with simian immunodeficiency virus (SIV) following SIV nucleocapsid mutant DNA vaccination.
    Gorelick RJ; Lifson JD; Yovandich JL; Rossio JL; Piatak M; Scarzello AJ; Knott WB; Bess JW; Fisher BA; Flynn BM; Henderson LE; Arthur LO; Benveniste RE
    J Med Primatol; 2000 Aug; 29(3-4):209-19. PubMed ID: 11085583
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.
    Nilsson C; Sutter G; Walther-Jallow L; Ten Haaft P; Åkerblom L; Heeney J; Erfle V; Böttiger P; Biberfeld G; Thorstensson R
    J Gen Virol; 2002 Apr; 83(Pt 4):807-818. PubMed ID: 11907330
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.
    Vaccari M; Keele BF; Bosinger SE; Doster MN; Ma ZM; Pollara J; Hryniewicz A; Ferrari G; Guan Y; Forthal DN; Venzon D; Fenizia C; Morgan T; Montefiori D; Lifson JD; Miller CJ; Silvestri G; Rosati M; Felber BK; Pavlakis GN; Tartaglia J; Franchini G
    J Virol; 2013 Mar; 87(6):3538-48. PubMed ID: 23325681
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Lu S; Arthos J; Montefiori DC; Yasutomi Y; Manson K; Mustafa F; Johnson E; Santoro JC; Wissink J; Mullins JI; Haynes JR; Letvin NL; Wyand M; Robinson HL
    J Virol; 1996 Jun; 70(6):3978-91. PubMed ID: 8648735
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines.
    Jones L; Ahmad S; Chan K; Verardi P; Morton WR; Grant R; Yilma T
    J Med Primatol; 2000 Aug; 29(3-4):231-9. PubMed ID: 11085585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.